CUSTODY DISPUTES INVOLVING GENETIC MODIFICATION: LEGAL FRAMEWORK AND JUDICIAL PRECEDENTS

1. INTRODUCTION

Custody disputes involving genetic modification arise when parents or guardians disagree over the upbringing, medical treatment, reproductive decisions, or legal responsibility concerning a child whose genetic characteristics have been deliberately altered through biotechnology. Such disputes may involve CRISPR gene editing, embryo modification, inherited genetic disease prevention, mitochondrial replacement, or other reproductive technologies.

These disputes raise complex questions concerning parental authority, bodily autonomy, medical consent, child welfare, reproductive rights, and ethical responsibility. The central legal question is whether genetic modification can influence custody decisions and whether a parent can claim superior custody rights because they authorised or opposed a particular genetic intervention.

Generally, genetic modification does not automatically determine parental fitness or custody. Courts must prioritise the child's best interests and protect the child's dignity, health, and fundamental rights.

2. LEGAL FRAMEWORK GOVERNING GENETIC MODIFICATION AND CHILD CUSTODY

A. CONSTITUTIONAL PROTECTION

In India, Article 21 protects life, personal liberty, dignity, and bodily autonomy. These principles are relevant when parents disagree about genetic interventions affecting a child's health or future medical treatment.

Articles 14 and 15 provide equality protections, preventing arbitrary or discriminatory treatment based on genetic characteristics.

B. JUVENILE JUSTICE AND CHILD WELFARE PRINCIPLES

The Juvenile Justice (Care and Protection of Children) Act, 2015 establishes child-centred protection principles. The child's welfare, dignity, and best interests are central considerations in decisions concerning vulnerable children.

C. GUARDIANSHIP AND CUSTODY LAW

The Guardians and Wards Act, 1890 provides the framework for judicial appointment of guardians and determination of guardianship disputes. Section 17 requires courts to consider the welfare of the minor, including age, circumstances, and relevant relationships.

The Hindu Minority and Guardianship Act, 1956, particularly Section 13, establishes that the welfare of the minor is paramount in determining guardianship.

D. GENETIC MODIFICATION REGULATION

The Department of Biotechnology's National Guidelines for Stem Cell Research and applicable biomedical research ethics requirements regulate relevant research activities. Genetic interventions involving human embryos also raise substantial ethical and regulatory restrictions. There is no general parental entitlement to authorise experimental heritable human genome editing.

3. MAJOR LEGAL ISSUES IN GENETIC MODIFICATION CUSTODY DISPUTES

A. DISAGREEMENT OVER GENETIC INTERVENTIONS

One parent may support genetic modification to prevent inherited disease, while the other may oppose it because of safety concerns, religious beliefs, or ethical objections. Courts must distinguish medically justified treatment from experimental or non-therapeutic enhancement.

B. CHILD'S BODILY AUTONOMY

Parents cannot necessarily exercise unlimited authority over medical interventions affecting a child. Courts must consider medical necessity, potential harm, future autonomy, and the child's ability to participate in decisions.

C. GENETIC DISCRIMINATION

A parent should not automatically lose custody because of their own genetic condition or because the child has been genetically modified. Decisions must be based on demonstrated parenting capacity and the child's welfare rather than genetic prejudice.

4. IMPORTANT JUDICIAL DECISIONS

1. Githa Hariharan v. Reserve Bank of India (1999) — Direct guardianship authority.

The Supreme Court of India interpreted parental guardianship provisions and recognised the importance of the mother's role as a natural guardian. The judgment is relevant when determining parental authority over decisions concerning genetically modified children.

2. Roxann Sharma v. Arun Sharma (2015) — Direct custody authority.

The Supreme Court emphasised the welfare of the child in custody proceedings and considered the statutory framework governing custody of young children. It supports an individualised assessment rather than automatic preference based on parental claims.

3. Nil Ratan Kundu v. Abhijit Kundu (2008) — Direct custody authority.

The Supreme Court held that the welfare of the minor is the paramount consideration in custody proceedings. Financial superiority or parental entitlement alone cannot determine custody.

4. Davis v. Davis (1992), 842 S.W.2d 588 — Analogous reproductive technology authority.

The Tennessee Supreme Court considered competing parental interests concerning frozen embryos. The judgment is relevant to disputes involving reproductive decisions and the legal status of genetically modified embryos.

5. Kass v. Kass (1998), 696 N.E.2d 174 — Analogous embryo custody authority.

The New York Court of Appeals considered disputes concerning stored embryos and the interpretation of agreements governing their disposition. Its reasoning is relevant to parental disagreements involving reproductive biotechnology.

6. A.Z. v. B.Z. (2000), 725 N.E.2d 1051 — Analogous reproductive rights authority.

The Massachusetts Supreme Judicial Court addressed a dispute involving frozen embryos and rejected enforcement of an agreement that would compel reproductive use against one party's wishes. It illustrates the importance of reproductive autonomy.

7. Evans v. United Kingdom (2007), Application No. 6339/05 — Analogous human rights authority.

The European Court of Human Rights examined competing reproductive rights concerning stored embryos. The judgment demonstrates that reproductive autonomy and consent remain important even when biotechnology creates complex parental interests.

5. JUDICIAL APPROACH TO CUSTODY DETERMINATION

Courts dealing with such disputes should consider:

The child's physical and psychological welfare.

Whether genetic modification was medically necessary or experimental.

The safety and long-term consequences of the intervention.

Each parent's capacity to provide appropriate care.

The child's medical records and independent expert opinions.

The child's age, maturity, and views where appropriate.

Risks of genetic discrimination, exploitation, or unnecessary treatment.

Courts may obtain independent medical evidence and impose appropriate conditions concerning treatment, access to medical records, and decision-making responsibilities.

6. LIABILITY AND PRACTICAL COMPLIANCE

Parents, medical practitioners, and research institutions may face legal consequences for unauthorised experimentation, negligent treatment, fraudulent consent, or unlawful genetic interventions. Relevant consequences may include civil liability, professional disciplinary proceedings, regulatory action, and criminal liability where statutory offences are established.

Practical safeguards include documented parental consent, independent medical assessment, transparent disclosure of genetic risks, protection of the child's medical information, and judicial supervision where parental disagreement creates a serious risk to the child.

7. CONCLUSION

Custody disputes involving genetic modification require courts to balance reproductive autonomy, parental rights, medical ethics, and the fundamental welfare of children. Indian guardianship and custody legislation provides the principal legal framework, while international embryo-disposition and reproductive-rights decisions offer useful analogous precedents. Genetic modification alone should neither establish nor defeat parental custody rights. The decisive consideration must remain the child's best interests, physical safety, dignity, and future autonomy.